1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) decreases glutamate uptake in cultured astrocytes
- PMID: 9109551
- DOI: 10.1046/j.1471-4159.1997.68052216.x
1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) decreases glutamate uptake in cultured astrocytes
Abstract
The deleterious effect of the parkinsonian neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) on dopaminergic neurons of the substantia nigra is well established. In addition, increased glutamatergic drive to basal ganglia output nuclei is considered a likely contributor to the pathogenesis of Parkinson's disease. One possibility for the increased excitatory tone may be related to an impairment in glutamate uptake. As astrocytes possess efficient transport mechanisms for both MPTP and glutamate, we have examined the effect of this agent on D-aspartate uptake into these cells. Treatment of cultures with 50 microM MPTP for 24 h decreased uptake by 39%. Kinetic analysis revealed that this effect was due to a 35% decrease in Vmax with no change in the Km. Treatment with deprenyl, a monoamine oxidase B inhibitor, produced a complete reversal of MPTP-induced uptake inhibition, but was ineffective following exposure of cells to the MPTP metabolite, 1-methyl-4-phenylpyridinium (MPP+). Removal of MPTP from cultures resulted in a complete restoration of glutamate uptake after 24 h. These results show that MPTP reversibly compromises glutamate uptake in cultured astrocytes, which is dependent on the conversion of MPTP to MPP+. Such findings suggest that the glutamate transporter in astrocytes plays an important role in MPTP-induced neurotoxicity and possibly in parkinsonism.
Similar articles
-
Astrocytes convert the parkinsonism inducing neurotoxin, MPTP, to its active metabolite, MPP+.Neurosci Lett. 1987 Apr 10;75(3):323-8. doi: 10.1016/0304-3940(87)90543-x. Neurosci Lett. 1987. PMID: 3495754
-
Oxidative stress induced by MPTP and MPP(+): selective vulnerability of cultured mouse astrocytes.Brain Res. 1999 Jul 31;836(1-2):237-44. doi: 10.1016/s0006-8993(99)01661-3. Brain Res. 1999. PMID: 10415427
-
Toxic effects of MPP(+) and MPTP in PC12 cells independent of reactive oxygen species formation.Brain Res. 2001 Jun 29;905(1-2):199-206. doi: 10.1016/s0006-8993(01)02551-3. Brain Res. 2001. PMID: 11423095
-
A model of chronic neurotoxicity: long-term retention of the neurotoxin 1-methyl-4-phenylpyridinium (MPP+) within catecholaminergic neurons.Neurotoxicology. 1991 Summer;12(2):285-302. Neurotoxicology. 1991. PMID: 1956587 Review.
-
Metallobiology of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine neurotoxicity.Metallomics. 2013 Feb;5(2):91-109. doi: 10.1039/c2mt20164j. Metallomics. 2013. PMID: 23322189 Review.
Cited by
-
Ceftriaxone ameliorates motor deficits and protects dopaminergic neurons in 6-hydroxydopamine-lesioned rats.ACS Chem Neurosci. 2012 Jan 18;3(1):22-30. doi: 10.1021/cn200072h. Epub 2011 Oct 26. ACS Chem Neurosci. 2012. PMID: 22860178 Free PMC article.
-
Overview of Glutamatergic Dysregulation in Central Pathologies.Biomolecules. 2015 Nov 11;5(4):3112-41. doi: 10.3390/biom5043112. Biomolecules. 2015. PMID: 26569330 Free PMC article. Review.
-
System x(c)- activity and astrocytes are necessary for interleukin-1 beta-mediated hypoxic neuronal injury.J Neurosci. 2007 Sep 19;27(38):10094-105. doi: 10.1523/JNEUROSCI.2459-07.2007. J Neurosci. 2007. PMID: 17881516 Free PMC article.
-
Focal cerebral ischemic injury decreases calbindin expression in brain tissue and HT22 cells.Lab Anim Res. 2013 Sep;29(3):156-61. doi: 10.5625/lar.2013.29.3.156. Epub 2013 Sep 27. Lab Anim Res. 2013. PMID: 24106510 Free PMC article.
-
The role of glutamate transporters in neurodegenerative diseases and potential opportunities for intervention.Neurochem Int. 2007 Nov-Dec;51(6-7):333-55. doi: 10.1016/j.neuint.2007.03.012. Epub 2007 Apr 19. Neurochem Int. 2007. PMID: 17517448 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials